Global Vigabatrin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Vigabatrin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Vigabatrin Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Tablet
1.2.3 Powder
1.3 Market Segment by Application
1.3.1 Global Vigabatrin Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Infantile Spasms (IS)
1.3.3 Partial-Onset Seizures
1.3.4 Refractory Complex Partial Seizures
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Vigabatrin Market Size (2017-2028)
2.1.1 Global Vigabatrin Revenue (2017-2028)
2.1.2 Global Vigabatrin Sales (2017-2028)
2.2 Global Vigabatrin Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Vigabatrin Sales by Regions (2017-2022)
2.2.2 Global Vigabatrin Revenue by Regions (2017-2022)
2.3 Global Vigabatrin Market Size Forecast by Region
2.3.1 Global Vigabatrin Sales Forecast by Region (2023-2028)
2.3.2 Global Vigabatrin Revenue Forecast by Region (2023-2028)
2.4 Global Top Vigabatrin Regions (Countries) Ranking by Market Size
2.5 Vigabatrin Market Dynamics
2.5.1 Vigabatrin Market Trends
2.5.2 Vigabatrin Market Drivers
2.5.3 Vigabatrin Market Challenges
2.5.4 Vigabatrin Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Vigabatrin Manufacturers by Sales (2017-2022)
3.1.1 Global Vigabatrin Sales by Manufacturers (2017-2022)
3.1.2 Global Vigabatrin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Vigabatrin Sales in 2021
3.2 Global Top Manufacturers Vigabatrin by Revenue
3.2.1 Global Vigabatrin Revenue by Manufacturers (2017-2022)
3.2.2 Top Vigabatrin Manufacturers Covered: Ranking by Revenue
3.2.3 Global Vigabatrin Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Vigabatrin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vigabatrin as of 2021)
3.4 Global Vigabatrin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Vigabatrin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Vigabatrin Market
3.7 Key Manufacturers Vigabatrin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Vigabatrin Market Size by Type
4.1 Global Vigabatrin Historic Market Review by Type (2017-2022)
4.1.1 Global Vigabatrin Sales Market Share by Type (2017-2022)
4.1.2 Global Vigabatrin Revenue Market Share by Type (2017-2022)
4.1.3 Vigabatrin Price by Type (2017-2022)
4.2 Global Vigabatrin Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Vigabatrin Sales Forecast by Type (2023-2028)
4.2.2 Global Vigabatrin Revenue Forecast by Type (2023-2028)
4.2.3 Vigabatrin Price Forecast by Type (2023-2028)
5 Global Vigabatrin Market Size by Application
5.1 Global Vigabatrin Historic Market Review by Application (2017-2022)
5.1.1 Global Vigabatrin Sales Market Share by Application (2017-2022)
5.1.2 Global Vigabatrin Revenue Market Share by Application (2017-2022)
5.1.3 Vigabatrin Price by Application (2017-2022)
5.2 Global Vigabatrin Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Vigabatrin Sales Forecast by Application (2023-2028)
5.2.2 Global Vigabatrin Revenue Forecast by Application (2023-2028)
5.2.3 Vigabatrin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vigabatrin Sales Breakdown by Company
6.1.1 North America Vigabatrin Sales by Company (2017-2022)
6.1.2 North America Vigabatrin Revenue by Company (2017-2022)
6.2 North America Vigabatrin Market Size by Type
6.2.1 North America Vigabatrin Sales by Type (2017-2028)
6.2.2 North America Vigabatrin Revenue by Type (2017-2028)
6.3 North America Vigabatrin Market Size by Application
6.3.1 North America Vigabatrin Sales by Application (2017-2028)
6.3.2 North America Vigabatrin Revenue by Application (2017-2028)
6.4 North America Vigabatrin Market Size by Country
6.4.1 North America Vigabatrin Sales by Country (2017-2028)
6.4.2 North America Vigabatrin Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Vigabatrin Sales Breakdown by Company
7.1.1 Europe Vigabatrin Sales by Company (2017-2022)
7.1.2 Europe Vigabatrin Revenue by Company (2017-2022)
7.2 Europe Vigabatrin Market Size by Type
7.2.1 Europe Vigabatrin Sales by Type (2017-2028)
7.2.2 Europe Vigabatrin Revenue by Type (2017-2028)
7.3 Europe Vigabatrin Market Size by Application
7.3.1 Europe Vigabatrin Sales by Application (2017-2028)
7.3.2 Europe Vigabatrin Revenue by Application (2017-2028)
7.4 Europe Vigabatrin Market Size by Country
7.4.1 Europe Vigabatrin Sales by Country (2017-2028)
7.4.2 Europe Vigabatrin Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vigabatrin Sales Breakdown by Company
8.1.1 Asia Pacific Vigabatrin Sales by Company (2017-2022)
8.1.2 Asia Pacific Vigabatrin Revenue by Company (2017-2022)
8.2 Asia Pacific Vigabatrin Market Size by Type
8.2.1 Asia Pacific Vigabatrin Sales by Type (2017-2028)
8.2.2 Asia Pacific Vigabatrin Revenue by Type (2017-2028)
8.3 Asia Pacific Vigabatrin Market Size by Application
8.3.1 Asia Pacific Vigabatrin Sales by Application (2017-2028)
8.3.2 Asia Pacific Vigabatrin Revenue by Application (2017-2028)
8.4 Asia Pacific Vigabatrin Market Size by Region
8.4.1 Asia Pacific Vigabatrin Sales by Region
8.4.2 Asia Pacific Vigabatrin Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Vigabatrin Sales Breakdown by Company
9.1.1 Latin America Vigabatrin Sales by Company (2017-2022)
9.1.2 Latin America Vigabatrin Revenue by Company (2017-2022)
9.2 Latin America Vigabatrin Market Size by Type
9.2.1 Latin America Vigabatrin Sales by Type (2017-2028)
9.2.2 Latin America Vigabatrin Revenue by Type (2017-2028)
9.3 Latin America Vigabatrin Market Size by Application
9.3.1 Latin America Vigabatrin Sales by Application (2017-2028)
9.3.2 Latin America Vigabatrin Revenue by Application (2017-2028)
9.4 Latin America Vigabatrin Market Size by Country
9.4.1 Latin America Vigabatrin Sales by Country (2017-2028)
9.4.2 Latin America Vigabatrin Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vigabatrin Sales Breakdown by Company
10.1.1 Middle East and Africa Vigabatrin Sales by Company (2017-2022)
10.1.2 Middle East and Africa Vigabatrin Revenue by Company (2017-2022)
10.2 Middle East and Africa Vigabatrin Market Size by Type
10.2.1 Middle East and Africa Vigabatrin Sales by Type (2017-2028)
10.2.2 Middle East and Africa Vigabatrin Revenue by Type (2017-2028)
10.3 Middle East and Africa Vigabatrin Market Size by Application
10.3.1 Middle East and Africa Vigabatrin Sales by Application (2017-2028)
10.3.2 Middle East and Africa Vigabatrin Revenue by Application (2017-2028)
10.4 Middle East and Africa Vigabatrin Market Size by Country
10.4.1 Middle East and Africa Vigabatrin Sales by Country (2017-2028)
10.4.2 Middle East and Africa Vigabatrin Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Sanofi Vigabatrin Products and Services
11.1.5 Sanofi Vigabatrin SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Benta Pharma Industries
11.2.1 Benta Pharma Industries Corporation Information
11.2.2 Benta Pharma Industries Overview
11.2.3 Benta Pharma Industries Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Benta Pharma Industries Vigabatrin Products and Services
11.2.5 Benta Pharma Industries Vigabatrin SWOT Analysis
11.2.6 Benta Pharma Industries Recent Developments
11.3 Dr. Fisher Farma
11.3.1 Dr. Fisher Farma Corporation Information
11.3.2 Dr. Fisher Farma Overview
11.3.3 Dr. Fisher Farma Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Dr. Fisher Farma Vigabatrin Products and Services
11.3.5 Dr. Fisher Farma Vigabatrin SWOT Analysis
11.3.6 Dr. Fisher Farma Recent Developments
11.4 Lundbeck
11.4.1 Lundbeck Corporation Information
11.4.2 Lundbeck Overview
11.4.3 Lundbeck Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Lundbeck Vigabatrin Products and Services
11.4.5 Lundbeck Vigabatrin SWOT Analysis
11.4.6 Lundbeck Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Overview
11.5.3 Novartis Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Novartis Vigabatrin Products and Services
11.5.5 Novartis Vigabatrin SWOT Analysis
11.5.6 Novartis Recent Developments
11.6 Perrigo
11.6.1 Perrigo Corporation Information
11.6.2 Perrigo Overview
11.6.3 Perrigo Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Perrigo Vigabatrin Products and Services
11.6.5 Perrigo Vigabatrin SWOT Analysis
11.6.6 Perrigo Recent Developments
11.7 Grindeks
11.7.1 Grindeks Corporation Information
11.7.2 Grindeks Overview
11.7.3 Grindeks Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Grindeks Vigabatrin Products and Services
11.7.5 Grindeks Vigabatrin SWOT Analysis
11.7.6 Grindeks Recent Developments
11.8 Endo International
11.8.1 Endo International Corporation Information
11.8.2 Endo International Overview
11.8.3 Endo International Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Endo International Vigabatrin Products and Services
11.8.5 Endo International Vigabatrin SWOT Analysis
11.8.6 Endo International Recent Developments
11.9 Amneal Pharma
11.9.1 Amneal Pharma Corporation Information
11.9.2 Amneal Pharma Overview
11.9.3 Amneal Pharma Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Amneal Pharma Vigabatrin Products and Services
11.9.5 Amneal Pharma Vigabatrin SWOT Analysis
11.9.6 Amneal Pharma Recent Developments
11.10 Cipla
11.10.1 Cipla Corporation Information
11.10.2 Cipla Overview
11.10.3 Cipla Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Cipla Vigabatrin Products and Services
11.10.5 Cipla Vigabatrin SWOT Analysis
11.10.6 Cipla Recent Developments
11.11 Upsher-Smith
11.11.1 Upsher-Smith Corporation Information
11.11.2 Upsher-Smith Overview
11.11.3 Upsher-Smith Vigabatrin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Upsher-Smith Vigabatrin Products and Services
11.11.5 Upsher-Smith Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Vigabatrin Value Chain Analysis
12.2 Vigabatrin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vigabatrin Production Mode & Process
12.4 Vigabatrin Sales and Marketing
12.4.1 Vigabatrin Sales Channels
12.4.2 Vigabatrin Distributors
12.5 Vigabatrin Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Vigabatrin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablet
Table 3. Major Manufacturers of Powder
Table 4. Global Vigabatrin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Vigabatrin Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Vigabatrin Sales by Region (2017-2022) & (K Units)
Table 7. Global Vigabatrin Sales Market Share by Region (2017-2022)
Table 8. Global Vigabatrin Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Vigabatrin Revenue Market Share by Region (2017-2022)
Table 10. Global Vigabatrin Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Vigabatrin Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Vigabatrin Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Vigabatrin Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Vigabatrin Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Vigabatrin Market Trends
Table 16. Vigabatrin Market Drivers
Table 17. Vigabatrin Market Challenges
Table 18. Vigabatrin Market Restraints
Table 19. Global Vigabatrin Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Vigabatrin Sales Share by Manufacturers (2017-2022)
Table 21. Global Vigabatrin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Vigabatrin Manufacturers by Revenue (US$ Million) in 2021
Table 23. Vigabatrin Revenue Share by Manufacturers (2017-2022)
Table 24. Global Vigabatrin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vigabatrin as of 2021)
Table 26. Key Manufacturers Vigabatrin Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
Table 27. Key Manufacturers Vigabatrin Plants/Factories Distribution
Table 28. Key Manufacturers Vigabatrin Area Served
Table 29. Date of Key Manufacturers Enter into Vigabatrin Market
Table 30. Key Manufacturers Vigabatrin Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Vigabatrin Sales (K Units) by Type (2017-2022)
Table 33. Global Vigabatrin Sales Share by Type (2017-2022)
Table 34. Global Vigabatrin Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Vigabatrin Price (K Units) by Type (2017-2022)
Table 36. Global Vigabatrin Sales (K Units) by Type (2023-2028)
Table 37. Global Vigabatrin Sales Share by Type (2023-2028)
Table 38. Global Vigabatrin Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Vigabatrin Revenue Share by Type (2023-2028)
Table 40. Global Vigabatrin Price (K Units) by Type (2023-2028)
Table 41. Global Vigabatrin Sales (K Units) by Application (2017-2022)
Table 42. Global Vigabatrin Sales Share by Application (2017-2022)
Table 43. Global Vigabatrin Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Vigabatrin Price (K Units) by Application (2017-2022)
Table 45. Global Vigabatrin Sales (K Units) by Application (2023-2028)
Table 46. Global Vigabatrin Sales Share by Application (2023-2028)
Table 47. Global Vigabatrin Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Vigabatrin Revenue Share by Application (2023-2028)
Table 49. Global Vigabatrin Price (K Units) by Application (2023-2028)
Table 50. North America Vigabatrin Sales by Company (2017-2022) & (K Units)
Table 51. North America Vigabatrin Sales Market Share by Company (2017-2022)
Table 52. North America Vigabatrin Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Vigabatrin Revenue Market Share by Company (2017-2022)
Table 54. North America Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 55. North America Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 56. North America Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 59. North America Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 60. North America Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Vigabatrin Sales by Country (2017-2022) & (K Units)
Table 63. North America Vigabatrin Sales by Country (2023-2028) & (K Units)
Table 64. North America Vigabatrin Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Vigabatrin Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Vigabatrin Sales by Company (2017-2022) & (K Units)
Table 67. Europe Vigabatrin Sales Market Share by Company (2017-2022)
Table 68. Europe Vigabatrin Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Vigabatrin Revenue Market Share by Company (2017-2022)
Table 70. Europe Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 71. Europe Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 72. Europe Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 75. Europe Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 76. Europe Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Vigabatrin Sales by Country (2017-2022) & (K Units)
Table 79. Europe Vigabatrin Sales by Country (2023-2028) & (K Units)
Table 80. Europe Vigabatrin Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Vigabatrin Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Vigabatrin Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Vigabatrin Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Vigabatrin Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Vigabatrin Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Vigabatrin Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Vigabatrin Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Vigabatrin Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Vigabatrin Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Vigabatrin Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Vigabatrin Sales Market Share by Company (2017-2022)
Table 100. Latin America Vigabatrin Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Vigabatrin Revenue Market Share by Company (2017-2022)
Table 102. Latin America Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Vigabatrin Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Vigabatrin Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Vigabatrin Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Vigabatrin Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Vigabatrin Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Vigabatrin Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Vigabatrin Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Vigabatrin Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Vigabatrin Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Vigabatrin Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Vigabatrin Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Vigabatrin Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Vigabatrin Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Vigabatrin Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Vigabatrin Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Vigabatrin Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Vigabatrin Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Vigabatrin Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Vigabatrin Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Vigabatrin Revenue by Country (2023-2028) & (US$ Million)
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Overview
Table 132. Sanofi Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 133. Sanofi Vigabatrin Product and Services
Table 134. Sanofi Vigabatrin SWOT Analysis
Table 135. Sanofi Recent Developments
Table 136. Benta Pharma Industries Corporation Information
Table 137. Benta Pharma Industries Description and Overview
Table 138. Benta Pharma Industries Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 139. Benta Pharma Industries Vigabatrin Product and Services
Table 140. Benta Pharma Industries Vigabatrin SWOT Analysis
Table 141. Benta Pharma Industries Recent Developments
Table 142. Dr. Fisher Farma Corporation Information
Table 143. Dr. Fisher Farma Description and Overview
Table 144. Dr. Fisher Farma Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 145. Dr. Fisher Farma Vigabatrin Product and Services
Table 146. Dr. Fisher Farma Vigabatrin SWOT Analysis
Table 147. Dr. Fisher Farma Recent Developments
Table 148. Lundbeck Corporation Information
Table 149. Lundbeck Description and Overview
Table 150. Lundbeck Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 151. Lundbeck Vigabatrin Product and Services
Table 152. Lundbeck Vigabatrin SWOT Analysis
Table 153. Lundbeck Recent Developments
Table 154. Novartis Corporation Information
Table 155. Novartis Description and Overview
Table 156. Novartis Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 157. Novartis Vigabatrin Product and Services
Table 158. Novartis Vigabatrin SWOT Analysis
Table 159. Novartis Recent Developments
Table 160. Perrigo Corporation Information
Table 161. Perrigo Description and Overview
Table 162. Perrigo Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 163. Perrigo Vigabatrin Product and Services
Table 164. Perrigo Vigabatrin SWOT Analysis
Table 165. Perrigo Recent Developments
Table 166. Grindeks Corporation Information
Table 167. Grindeks Description and Overview
Table 168. Grindeks Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 169. Grindeks Vigabatrin Product and Services
Table 170. Grindeks Vigabatrin SWOT Analysis
Table 171. Grindeks Recent Developments
Table 172. Endo International Corporation Information
Table 173. Endo International Description and Overview
Table 174. Endo International Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 175. Endo International Vigabatrin Product and Services
Table 176. Endo International Vigabatrin SWOT Analysis
Table 177. Endo International Recent Developments
Table 178. Amneal Pharma Corporation Information
Table 179. Amneal Pharma Description and Overview
Table 180. Amneal Pharma Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 181. Amneal Pharma Vigabatrin Product and Services
Table 182. Amneal Pharma Vigabatrin SWOT Analysis
Table 183. Amneal Pharma Recent Developments
Table 184. Cipla Corporation Information
Table 185. Cipla Description and Overview
Table 186. Cipla Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 187. Cipla Vigabatrin Product and Services
Table 188. Cipla Vigabatrin SWOT Analysis
Table 189. Cipla Recent Developments
Table 190. Upsher-Smith Corporation Information
Table 191. Upsher-Smith Description and Overview
Table 192. Upsher-Smith Vigabatrin Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 193. Upsher-Smith Vigabatrin Product and Services
Table 194. Upsher-Smith Recent Developments
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Vigabatrin Distributors List
Table 198. Vigabatrin Customers List
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Vigabatrin Product Picture
Figure 2. Global Vigabatrin Sales Market Share by Type in 2021 & 2028
Figure 3. Tablet Product Picture
Figure 4. Powder Product Picture
Figure 5. Global Vigabatrin Sales Market Share by Application in 2021 & 2028
Figure 6. Infantile Spasms (IS) Use Case
Figure 7. Partial-Onset Seizures Use Case
Figure 8. Refractory Complex Partial Seizures Use Case
Figure 9. Vigabatrin Report Years Considered
Figure 10. Global Vigabatrin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Vigabatrin Market Size 2017-2028 (US$ Million)
Figure 12. Global Vigabatrin Sales (2017-2022) & (K Units)
Figure 13. Global Vigabatrin Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Vigabatrin Sales Market Share by Region (2017-2022)
Figure 15. Global Vigabatrin Sales Market Share by Region in 2021
Figure 16. Global Vigabatrin Revenue Market Share by Region in 2017 VS 2021
Figure 17. Global Vigabatrin Sales Share by Manufacturers in 2021
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Vigabatrin Sales in 2021
Figure 19. Vigabatrin Revenue Share by Manufacturers in 2021
Figure 20. Vigabatrin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Vigabatrin Revenue Share by Type (2017-2022)
Figure 22. Global Vigabatrin Revenue Growth Rate by Type in 2017 & 2021
Figure 23. Global Vigabatrin Revenue Share by Application (2017-2022)
Figure 24. Global Vigabatrin Revenue Growth Rate by Application in 2017 & 2021
Figure 25. North America Vigabatrin Sales Market Share by Type (2017-2028)
Figure 26. North America Vigabatrin Revenue Market Share by Type (2017-2028)
Figure 27. North America Vigabatrin Sales Market Share by Application (2017-2028)
Figure 28. North America Vigabatrin Revenue Market Share by Application (2017-2028)
Figure 29. North America Vigabatrin Sales Share by Country (2017-2028)
Figure 30. North America Vigabatrin Revenue Share by Country (2017-2028)
Figure 31. United States Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 32. Canada Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 33. Europe Vigabatrin Sales Market Share by Type (2017-2028)
Figure 34. Europe Vigabatrin Revenue Market Share by Type (2017-2028)
Figure 35. Europe Vigabatrin Sales Market Share by Application (2017-2028)
Figure 36. Europe Vigabatrin Revenue Market Share by Application (2017-2028)
Figure 37. Europe Vigabatrin Sales Share by Country (2017-2028)
Figure 38. Europe Vigabatrin Revenue Share by Country (2017-2028)
Figure 39. Germany Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 40. France Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 41. U.K. Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 42. Italy Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 43. Russia Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 44. Asia Pacific Vigabatrin Sales Market Share by Type (2017-2028)
Figure 45. Asia Pacific Vigabatrin Revenue Market Share by Type (2017-2028)
Figure 46. Asia Pacific Vigabatrin Sales Market Share by Application (2017-2028)
Figure 47. Asia Pacific Vigabatrin Revenue Market Share by Application (2017-2028)
Figure 48. Asia Pacific Vigabatrin Sales Share by Region (2017-2028)
Figure 49. Asia Pacific Vigabatrin Revenue Share by Region (2017-2028)
Figure 50. China Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 51. Japan Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 52. South Korea Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 53. India Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 54. Australia Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 55. China Taiwan Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 56. Indonesia Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 57. Thailand Vigabatrin Revenue (2017-2028) & (US$ Million)
Figure 58. Malaysia Vigabatrin Revenue (2017-2028) & (US$ Millio

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs